SCHEMBL2465347

SCHEMBL2465347

O=C(O)COc1ccc(Br)cc1-c1nc(Cc2ccc(OC(F)(F)F)cc2)no1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 9/20 0.43
PPARA Q07869 2/20 0.43
PPARG P37231 1/20 0.43
PTGDR2 Q9Y5Y4 5/20 0.43
PTGER1 P34995 1/20 0.43
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
PSMB5 P28074 1/20 0.38
NMT1 P30419 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2464504 0.88 MAPT (0.50) PPARDPTGDR2PTGER1PSMB5NMT1
SCHEMBL1995885 0.88 PTGDR2 (0.47) PTGDR2PTGER1PRMT5WDR77NMT1
SCHEMBL1996328 0.86 PTGDR2 (0.56) PTGDR2PRMT5WDR77NMT1
SCHEMBL2000087 0.86 PPARD (0.50) PPARDPTGDR2
SCHEMBL1993270 0.85 ALDH1A1 (0.51) PTGDR2PRMT5WDR77NMT1
SCHEMBL2463039 0.85 PTGDR2 (0.47) PTGDR2PTGER1PRMT5WDR77NMT1
SCHEMBL2466354 0.84 PTGDR2 (0.47) PPARDPPARAPPARGPTGDR2PRMT5
SCHEMBL27829947 0.82 CHUK (0.47) PPARDPPARAPPARGNMT1
SCHEMBL2462176 0.82 LMNA (0.59) PTGDR2PRMT5WDR77PSMB5NMT1
SCHEMBL2465338 0.82 NMT1 (0.47) PTGDR2PRMT5WDR77PSMB5NMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-11-03 US disclosed
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-11-03 US disclosed
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-11-03 US disclosed
US-8022063-B2 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-09-20 US disclosed
US-8022063-B2 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-09-20 US disclosed
US-8022063-B2 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-09-20 US disclosed
EP-2336113-A1 CRTH2 Receptor Ligands for Medical Use 7TM Pharma A/S (DK) 2011-06-22 EP disclosed
US-20090099189-A1 CRTH2 Receptor Ligands For Medicinal Uses 7TM PHARMA A/S (DK) 2009-04-16 US disclosed
US-20090099189-A1 CRTH2 Receptor Ligands For Medicinal Uses 7TM PHARMA A/S (DK) 2009-04-16 US disclosed
US-20090099189-A1 CRTH2 Receptor Ligands For Medicinal Uses 7TM PHARMA A/S (DK) 2009-04-16 US disclosed
EP-1758579-A1 CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES 7TM Pharma A/S (DK) 2007-03-07 EP disclosed
WO-2005115382-A1 CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES 7TM PHARMA A/S (DK) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099189-A1 CRTH2 Receptor Ligands For Medicinal Uses HRH1, HRH2, HRH3 PPARD 1647/4885PPARA 1012/4885PPARG 525/4885
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses HRH1, HRH2, HRH4 PPARD 1506/4885PPARA 1034/4885PPARG 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.